All In Biotech

Drug Trial Radar · NCT02509299

Effect of Physiotherapy in Hospitalized COPD Patients

Effect of Different Physiotherapy Treatments in Hospitalized COPD Patients

Last checked: Nov 20, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

49

Actual

Start

Sep 1, 2019

Primary completion

Nov 20, 2019

Study completion Dec 14, 2019

Sponsor

Lead sponsor
Universidad de GranadaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 28, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Chronic obstructive pulmonary disease (COPD) impacts negatively on the balance and strength of patients. Several studies have shown that acute exacerbations (AEs) decrease, pulmonary function and survival of COPD patients, and there are a lot of physiotherapy interventions to improve it during the hospital stay. The objective of the present study is to examine the effects of a physical therapy program on balance and strength in COPD patients hospitalized due to acute exacerbation.

Conditions

  • COPD

Interventions

  • Physiotherapy program 1Other

    The standard medical treatment and additionally they will receive physiotherapy. The program will be performed every day during the hospital stay and it will include global active range of motion (ROM) exercises and muscle strengthening like upper and lower limbs flexion-extension do single-leg stance, and sit to stand exercises.

  • Physiotherapy program 2Other

    COPD patients included in this group will receive the standard medical treatment and additionally, they will receive a physiotherapy program. The program will be performed every day during the hospital stay and included neuromuscular stimulation therapy on quadriceps accompanied by lower limbs exercises

  • Standard medical treatmentDrug

    The standard medical treatment consists on: * Inhaled bronchodilators: Short acting inhaled β2 agonists ( salbutamol and terbutaline) and anticholinergic agents (ipratropium and oxitropium bromide). * Glucocorticoids: Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide, depending on the expert criteria. \- Antibiotics: The antibiotics were administered according to the GOLD criteria including the β-lactamase inhibitor and fluoroquinolones.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lower limb strengthTime frame: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
  2. BalanceTime frame: Participants will be followed for the duration of hospital stay, an expected average of 9 days.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Physical Therapy

    Granada, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.